Related Experiment Video
Updated: Jun 27, 2026

08:27
Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
Potential of nanocarriers in genetic immunization
Kapil Khatri1, Amit K Goyal, Suresh P Vyas
1Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, MP 470003, India.
Recent Patents on Drug Delivery & Formulation
|December 17, 2008
Summary
Non-viral nanocarriers offer a safe and effective method for DNA vaccination, enhancing both humoral and cell-mediated immunity against infectious agents. These systems improve gene delivery for genetic immunization strategies.
Area of Science:
- Immunology
- Biotechnology
- Nanotechnology
Background:
- DNA vaccination, or genetic immunization, induces both humoral and cell-mediated immune responses.
- Genetic vaccines can mitigate the pathology of various infections.
- Efficient DNA vaccination requires overcoming gene transfection barriers.
Purpose of the Study:
- To review the potential of non-viral nanocarrier constructs for genetic immunization.
- To analyze issued patents in the field of DNA vaccination delivery systems.
- To detail various carrier systems used for plasmid DNA delivery.
Main Methods:
- Literature review of non-viral nanocarrier systems for DNA vaccination.
- Retrieval and analysis of US patent database records.
- Detailed examination of plasmid DNA delivery carrier systems.
Main Results:
- Non-viral systems are safer, cheaper, and capable of delivering larger DNA fragments compared to viral systems.
- Nanocarriers protect DNA from degradation and target antigen-presenting cells.
- A range of non-viral nanocarrier systems have been developed for genetic immunization.
Conclusions:
- Non-viral nanocarriers show significant potential for advancing genetic immunization strategies.
- These systems offer advantages in safety, cost-effectiveness, and delivery efficiency.
- Further development of non-viral nanocarriers could lead to improved vaccines against infectious diseases.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
